Orchid Pharma Limited (NSE:ORCHPHARMA)
India
· Delayed Price · Currency is INR 759.05
-8.00 (-1.04%)
May 19, 2025, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 38.90 billion as of May 19, 2025. Its market cap has decreased by -29.26% in one year.
Market Cap
38.90B
Enterprise Value
38.11B
Revenue
9.02B
Ranking
n/a
PE Ratio
35.08
Stock Price
759.05
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 38.90B, an increase of 5,248.76%. That is a compound annual growth rate of 140.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 38.90B | -57.55% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | 4.98B | 584.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,162.61B |
| Divi's Laboratories | 1,667.01B |
| Cipla | 1,211.38B |
| Mankind Pharma | 1,061.44B |
| Apollo Hospitals Enterprise | 1,008.65B |
| Zydus Lifesciences | 908.33B |
| Aurobindo Pharma | 697.66B |
| Alkem Laboratories | 624.25B |